Kabra Drugs Board Meeting on Sep 2, 2026 for FY26 Reports & AGM
Kabra Drugs Ltd has announced a Board of Directors meeting scheduled for September 2, 2026. The meeting will primarily focus on approving the Director's Report and Corporate Governance Report for the financial year ending March 31, 2026. Key agenda items include the closure of the Register of Members and Share Transfer Books for the upcoming Annual General Meeting (AGM), fixing the AGM date, time, and venue, and appointing a scrutinizer. The board will also consider the re-appointment of Director Mr. Kuniamuthur Nanjappan Anand and the appointment of Internal Auditors for FY 2026-2027, as well as recommend the appointment of Ms. Moonam Kapoor as a Director and the Secretarial Auditor for a five-year term.
Key Highlights
- Board meeting scheduled for September 2, 2026.
- Approval of FY26 Director's and Corporate Governance Reports.
- Preparation for Annual General Meeting (AGM) including book closure.
- Consideration of director re-appointment and auditor appointments.
- Recommendation for new director appointment.
Price Impact
More from KABRADG